Unicycive Therapeutics, Inc., (UNCY) Social Stream
Unicycive Therapeutics Inc (UNCY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Unicycive Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
UNCY reports an average of 380.11% for its upside potential over the past 84 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
UNCY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of stocks in the nano market cap category, Unicycive Therapeutics Inc's average analyst price target is greater than nearly 100% of them.
- In the context of Healthcare stocks, Unicycive Therapeutics Inc's number of analysts covering the stock is higher than 4.68% of them.
- In terms of how Unicycive Therapeutics Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 94.52% of that group.
- In terms of how Unicycive Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 94.11% of that group.
In the Pharmaceutical Products industry, RNAZ, PTPI, and PRFX are the three stocks most similar to Unicycive Therapeutics Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for UNCY? Use POWR Ratings for clearer insight into price direction.